Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Individual Variation of the Genetic Response to Bisphenol A in Human Foreskin Fibroblast Cells Derived from Cryptorchidism and Hypospadias Patients

  • Xian-Yang Qin,

    Affiliations Health Risk Research Section, Research Center for Environmental Risk, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan, Department of Environmental Studies, Graduate School of Frontier Science, University of Tokyo, Kashiwa, Chiba, Japan

  • Hideko Sone ,

    hsone@nies.go.jp

    Affiliation Health Risk Research Section, Research Center for Environmental Risk, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan

  • Yoshiyuki Kojima,

    Affiliation Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan

  • Kentaro Mizuno,

    Affiliation Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan

  • Katsuhiko Ueoka,

    Affiliation Department of Surgical Subspecialties, National Research Center for Child Health and Development, Tokyo, Japan

  • Koji Muroya,

    Affiliation Division of Endocrinology and Metabolism, Kanagawa Children's Medical Center, Kanagawa, Yokohama, Japan

  • Mami Miyado,

    Affiliation Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development, Tokyo, Japan

  • Aya Hisada,

    Affiliation Department of Environmental Studies, Graduate School of Frontier Science, University of Tokyo, Kashiwa, Chiba, Japan

  • Hiroko Zaha,

    Affiliation Health Risk Research Section, Research Center for Environmental Risk, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan

  • Tomokazu Fukuda,

    Affiliation Department of Animal Production Science, Graduate School of Agricultural Science, Tohoku University, Sendai, Miyagi, Japan

  • Jun Yoshinaga,

    Affiliation Department of Environmental Studies, Graduate School of Frontier Science, University of Tokyo, Kashiwa, Chiba, Japan

  • Junzo Yonemoto,

    Affiliation Health Risk Research Section, Research Center for Environmental Risk, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan

  • Kenjiro Kohri,

    Affiliation Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan

  • Yutaro Hayashi,

    Affiliation Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan

  • Maki Fukami,

    Affiliation Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development, Tokyo, Japan

  •  [ ... ],
  • Tsutomu Ogata

    Affiliation Department of Pediatrics, University Hospital, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

  • [ view all ]
  • [ view less ]

Abstract

Background/Purpose

We hypothesized that polymorphic differences among individuals might cause variations in the effect that environmental endocrine disruptors (EEDs) have on male genital malformations (MGMs). In this study, individual variation in the genetic response to low-dose bisphenol A (BPA) was investigated in human foreskin fibroblast cells (hFFCs) derived from child cryptorchidism (CO) and hypospadias (HS) patients.

Methodology/Principal Findings

hFFCs were collected from control children without MGMs (n = 5) and child CO and HS patients (n = 8 and 21, respectively). BPA exposure (10 nM) was found to inhibit matrix metalloproteinase-11 (MMP11) expression in the HS group (0.74-fold, P = 0.0034) but not in the control group (0.93-fold, P = 0.84) and CO group (0.94-fold, P = 0.70). Significantly lower levels of MMP11 expression were observed in the HS group compared with the control group (0.80-fold, P = 0.0088) and CO group (0.79-fold, P = 0.039) in response to 10 nM BPA. The effect of single-nucleotide polymorphism rs5000770 (G>A), located within the aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) locus, on individual sensitivity to low-dose BPA was investigated in the HS group. A significant difference in neurotensin receptor 1 (NTSR1) expression in response to 10 nM BPA was observed between AA and AG/GG groups (n = 6 and 15, respectively. P = 0.031). However, no significant difference in ARNT2 expression was observed (P = 0.18).

Conclusions/Significance

This study advances our understanding of the specificity of low-dose BPA effects on human reproductive health. Our results suggest that genetic variability among individuals affects susceptibility to the effects of EEDs exposure as a potential cause of HS.

Introduction

Cryptorchidism (CO) and hypospadias (HS) are the two most common congenital male genital malformations (MGMs) with a global prevalence of approximately 2–9% and 0.2–1%, respectively [1], [2]. The etiologies of CO and HS are complicated and have been partly related with in utero exposure to environmental endocrine disruptors (EEDs) [3], [4], [5]. However, epidemiological studies on this issue have produced conflicting results [6]. It is believed that the effect of EEDs depend on several factors, including the dosage of EEDs exposure, the developmental stage during which EEDs exposure occurred, and genetic variability to the effects of EEDs exposure [7]. We have previously investigated the association between single-nucleotide polymorphisms (SNPs) of genes involved in EEDs metabolism and the risk of CO and HS in a Japanese population and found that SNP rs5000770 (G>A) within intron 1 of aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) was significantly associated at both allele and genotype levels with increased risk of CO and HS [8].

ARNT2 is a member of the basic helix-loop-helix Per-ARNT-SIM (bHLH-PAS) family of transcription factors that is involved in the regulation of many physiological pathways, including responses to environmental contaminants [9], [10]. Arnt2 plays pivotal roles in the regulation of early development in zebrafish [11] and ARNT2 knockout mice suffer severe developmental defects and die shortly after birth [12], [13]. ARNT2 polymorphisms have been linked with the risk of some specific congenital malformations in humans such as cleft palate [14]. However, little is known about the relationship of ARNT2 polymorphisms and the risk of MGMs. Therefore, we aimed to investigate whether the polymorphic differences among individuals might cause variations in the ability of EEDs to cause MGMs. It is likely that further investigations on this issue will shed increased light on the link between EEDs exposure and the development of MGMs.

Bisphenol A (BPA) is used extensively in the manufacture of the plastics used to make food and beverage containers and has a global production of over six billion pounds per year [15]. However BPA is a well-known estrogen-like EED. BPA has been detected in 92% of urine samples in a US reference population, suggesting that humans might be continuously exposed to this compound in their daily lives [16]. To better understand the molecular basis of the effect of low-dose BPA exposure on human reproductive health, we previously performed a genome-wide screen using human foreskin fibroblast cells (hFFCs) derived from child HS patients to identify novel targets of low-dose BPA exposure [17]. We reported that the expression of matrix metalloproteinase-11 (MMP11), a well-known effector of development and normal physiology, was downregulated by BPA in a dose-dependent manner. We also demonstrated that MMP11 expression was significantly lower in the HS group compared with that in the CO group. These findings indicated that MMP11 is an important target of low-dose BPA and the involvement of BPA in the development of HS might relate to downregulation of MMP11 expression.

In this study, to better understand the effect of BPA exposure on human reproductive health, individual susceptibility to low-dose BPA was investigated in hFFCs derived from child CO and HS patients. Human foreskin tissues obtained from patients with HS have been used as in vitro models to define the etiology of HS [18], [19]. In addition to MMP11, neurotensin receptor 1 (NTSR1), known to be involved in tumor progression by regulating a series of transforming functions such as cellular migration and invasion, was also selected as a candidate BPA-responsive gene [20]. We did not identify NTSR1 as a target of low-dose BPA in our previous genome-wide screen, probably owing to a lack of statistical significance [17]. However, this may indicate variability in gene expression levels among individuals in response to low-dose BPA exposure (Figure S1).

Materials and Methods

Sample collection

hFFCs were obtained from control children with concealed penis or phimosis and child HS and CO patients undergoing surgical procedures at the National Research Institute for Child Health and Development, Japan, during 2007–2009. With more details, foreskin specimens were obtained from children with HS and phimosis during HS repair and circumsicion, respectively. Then, the foreskin specimens were mechanically dissociated with scissors into small pieces and cultured on plastic plates. The adhered cells on the plate were then obtained as hFFCs. All subjects were of Japanese origin, and written informed consent was obtained from the guardians of each participant. This study was approved by the Institutional Ethics Committees of the Nagoya City University Graduate School of Medical Sciences, the National Research Institute for Child Health and Development and the National Institute for Environmental Studies.

Chemicals

Dimethyl sulfoxide (DMSO) was obtained from Sigma Chemical Co. (St. Louis, MO, USA), and BPA was obtained from Wako Industries (Osaka, Japan). DMSO was used as the primary solvent, and the DMSO solutions were further diluted in cell culture media prior to use. The final concentration of DMSO in media did not exceed 0.1% (vol/vol).

Cell culture

hFFCs were maintained in Dulbecco's modified Eagle's medium (DMEM)/Ham's F-12 (048-29785, Wako, Osaka, Japan) containing 10% fetal bovine serum (FBS; Mediatech, Herndon, VA, USA) and grown at 37°C in a 5% CO2 humidified incubator. For growth under steroid-free conditions, cells were seeded in phenol red-free DMEM/Ham's F-12 (045-30665, Wako) containing 5% charcoal/dextran-treated FBS (Hyclone, Logan, UT, USA). All culture media contained 100 U/ml penicillin/streptomycin and 2 mmol/L L-glutamine (Mediatech, Herndon, VA, USA).

RNA isolation and reverse-transcription polymerase chain reaction (RT-PCR)

Total RNA was isolated from cultured cells after treatment with DMSO or BPA for 24 h using an RNeasy Kit (Qiagen, Valencia, CA, USA) in accordance with the manufacturer's instructions. Quantification and quality assessment of the isolated RNA were performed using an Agilent Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA) and a NanoDrop spectrophotometer (NanoDrop products, Wilmington, DE, USA) in accordance with the manufacturer's instructions. Complementary DNA (cDNA) was synthesized using a High Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions. The primers (Forward: 5′-ACCCTCCGGAAATGGCTTCAGA-3′; Reverse: 5′-CATCGGTGGACTTGTTCCCTGTA-3′) for ARNT2 were designed and synthesized by Hokkaido System Science (Sapporo, Hokkaido, Japan). PCR reactions were performed on a GeneAmp® PCR System 9700 (Applied Biosystems) under the following cycling conditions: 94°C for 2 min, followed by 35 cycles of 98°C for 10 s, 60°C for 30 s and 68°C for 1 min. PCR products were then separated on 2% agarose gels containing 0.5 µl/ml ethidium bromide and imaged in a molecular imager (FX Pro Plus; Bio-Rad Laboratories, Hercules, CA, USA).

Real-time RT-PCR

Real-time PCR was performed using TaqMan® Gene Expression Master Mix (Applied Biosystems) in accordance with the manufacturer's instructions. TaqMan® Gene Expression Assays (Applied Biosystems) used in this study were: Hs00208298_m1 for ARNT2, Hs00171829_m1 for MMP11, Hs00901551_m1 for NTSR1, Hs99999903_m1 for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Hs99999903_m1 for beta-actin. The amplification reaction was performed in an ABI PRISM 7000 Sequence Detector (Applied Biosystems) under the following cycling conditions: 95°C for 15 min, followed by 40 cycles of 95°C for 15 s and 60°C for 60 s. Gene expression levels were calculated based on the threshold cycle using Sequence Detection System Software (Applied Biosystems). Gene expression was normalized against GAPDH expression and set to 1 for the control DMSO-treated cells.

Genotyping

SNPs were determined using the GoldenGate assay (Illumina, San Diego, CA, USA) as previously reported [8].

Statistical analysis

Quantitative data are expressed as the mean ± SEM. A non-parametric test, the Mann-Whitney U test, was applied to test for statistical significance. The effect of BPA compared with DMSO control was evaluated by a paired T-test (Wilcoxon) using R (version 2.15.0). Relationships were considered statistically significant at P<0.05.

Results

Samples

Thirty-four hFFCs derived from control children without distinct MGMs (n = 5; median age 5.3 yrs), HS (n = 21; median age 2.5 yrs) and CO (n = 8; median age 1.6 yrs) patients were collected. Detailed patient information is summarized in Table S1, including age, disease type and genotype of ARNT2 SNP, rs5000770.

Difference in ARNT2 mRNA levels in hFFCs derived from CO and HS patients

The mRNA levels of ARNT2 in the control, HS and CO groups are shown in Figure 1. The mean ARNT2 mRNA level, normalized to GAPDH, in the control group was 0.0094, in the HS group was 0.0084 and in the CO group was 0.0043. No significant difference was observed between the control group and HS group (P = 0.16), while lower ARNT2 expression was observed in CO group compared with control group only on the borderline of significance (P = 0.054).

thumbnail
Figure 1. ARNT2 mRNA levels in control children and child HS and CO patients.

ARNT2 expression were measured in hFFCs derived from the control group (n = 5), HS (n = 21) group and CO (n = 8) group by TaqMan® real-time PCR. (A) Boxplot and (B) summary of the quantitative data.

https://doi.org/10.1371/journal.pone.0052756.g001

Differences in the genetic response to BPA exposure in hFFCs derived from CO and HS patients

We confirmed the effect of BPA exposure on GAPDH expression and no effect was observed when GAPDH mRNA was normalized to beta-actin (Figure S2). Then, differences in hFFC MMP11 and NTSR1 expression in response to low-dose BPA exposure were compared among control, HS and CO groups. As shown in Figure 2A, MMP11 expression was significantly inhibited by exposure to 10 nM BPA in the HS group (0.74-fold compared with DMSO control, P = 0.0035), while no significant effect was observed in the control group (0.93-fold compared with DMSO control, P = 0.84) and CO group (0.94-fold compared with DMSO control, P = 0.20). Significantly lower MMP11 expression levels were observed in the HS group compared with the control group (0.80-fold, P = 0.0088) and CO group (0.79-fold, P = 0.039) in response to low-dose BPA exposure. As shown in Figure 2B, no significant effects in NTSR1 expression were observed by 10 nM BPA exposure in the control group (1.19-fold compared with DMSO control, P = 1.0), HS group (0.98-fold compared with DMSO control, P = 0.39) and CO group (0.75-fold compared with DMSO control, P = 0.20). In addition, no significant difference in NTSR1 expression levels was observed in the HS group or CO group compared with the control group in response to low-dose BPA exposure.

thumbnail
Figure 2. Difference in the genetic response to low-dose BPA in hFFCs derived from control children and child HS and CO patients.

Cells were treated with 10 nM BPA for 24 h, and then the expression of MMP11 (A) and NTSR1 (B) was measured by TaqMan® real-time PCR. Significance was evaluated by the Mann-Whitney U test or Wilcoxon test. The bottom numbers indicate the fold changes and P value induced by BPA compared with DMSO control.

https://doi.org/10.1371/journal.pone.0052756.g002

Effect of ARNT2 variants on ARNT2 mRNA levels and splicing

We then investigated the effect of SNP rs5000770 genotype on ARTN2 expression in the HS group. As shown in Figure 3A, the mean ARNT2 mRNA levels, normalized to GAPDH, in the AA group were 0.0074 (n = 6) and in the AG/GG group, 0.0088 (n = 15). These results indicated no significant difference in ARNT2 mRNA levels between the AA group and the AG/GG group (P = 0.18). Furthermore, as shown in Figure 3B, no significant effect of SNP rs5000770 genotype was observed in the splicing pattern of ARNT2 in either HS or CO groups.

thumbnail
Figure 3. Association between rs5000770 genotype and ARNT2 expression.

(A) Boxplot of the ARNT2 mRNA level in hFFCs from child HS patients with different genotypes (6 AA and 15 AG/GG) relative to GAPDH measured using TaqMan® real-time PCR. Statistical significance was evaluated by the Mann-Whitney U test. (B) Scheme of the quantitative PCR strategy for screening splicing variants. No splicing variant was detected using intron-spanning RT-PCR in hFFCs either from HS or CO patients.

https://doi.org/10.1371/journal.pone.0052756.g003

Effect of ARNT2 variants on the genetic response to low-dose BPA exposure

Finally, we investigated the effect of SNP rs5000770 genotype on the genetic response of hFFCs to low-dose BPA exposure in the HS group. As shown in Figure 4A, no significant difference in MMP11 expression in response to 10 nM BPA exposure was observed between the AA and AG/GG groups (P = 0.44). However, as shown in Figure 4B, a significant difference in NTSR1 gene expression in response to 10 nM BPA exposure was observed between the AA and AG/GG groups (P = 0.031). However, no significant effects of low-dose BPA exposure were observed in NTSR1 gene expression compared with DMSO control in either AA or AG/GG groups (1.16-fold; P = 0.56 and 0.90-fold; P = 0.19, respectively).

thumbnail
Figure 4. Effect of SNP rs5000770 genotype on the genetic response to low-dose BPA.

Cells were treated with 10 nM BPA for 24 h, and then MMP11 and NTSR1 mRNA levels were measured by TaqMan® real-time PCR. Boxplot of the quantitative data comparing MMP11 (A) and NTSR1 (B) expression in child HS patients with different genotypes (6 AA and 15 AG/GG). Significance was evaluated by the Mann-Whitney U test.

https://doi.org/10.1371/journal.pone.0052756.g004

Discussion

Variability in susceptibility to the effects of EEDs exposure has been considered as a contributing factor to MGMs [7]. However, to our knowledge, no previous report has tested this hypothesis. Thus, this study was initiated to investigate how the genetic response of individuals varied to low-dose BPA exposure using hFFCs derived from child CO and HS patients. Differences in MMP11 and NTSR1 expression in response to 10 nM BPA treatment in CO and HS groups were compared with that in control children. Furthermore, the effect of SNP rs5000770 (G>A) genotype on individual sensitivity to low-dose BPA was also investigated in the HS group. The concentration of BPA used in this study was 10 nM, which is below the dose of 50 µg/kg/day (approximately 200 nM for in vitro cell or organ culture studies) usually considered as safe for humans and in the concentration range of 1–19.4 nM that is commonly detected in human tissues and fluids [15], [21].

One of our most interesting results is the specificity of the effect of low-dose BPA on MMP11 expression. Despite increasing evidence that exposure to BPA causes adverse health effects in humans, controversy remains about the specificity of these effects [6]. In this study, we observed that 10 nM BPA exposure can significantly inhibit MMP11 expression in hFFCs derived from child HS but not control children and CO patients. We have recently identified that MMP11 is a novel target of low dose of BPA exposure and that BPA can inhibit MMP11 expression in a dose-dependent manner in hFFCs derived from child HS patients. Furthermore, we found that mRNA levels of MMP11 were significantly lower in the HS group compared with the control and CO groups suggesting that the involvement of BPA in the development of HS might be related with the downregulation of MMP11 [17]. The results of this study are in accord with this hypothesis. MMPs are known to be involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling [22], [23]. Knockdown of MMPs in Tribolium using genetic interference has been related with malformation in tracheal and gut development during beetle embryogenesis and pupal morphogenesis [24]. It is known that epithelial seam formation and remodeling during urethral formation play important roles in the etiology of HS. The urethral abnormalities seen in HS can be viewed as a failure of epithelial cell adhesion [25]. Therefore, if our hypothesis that downregulation of MMP11 plays an important role in the etiology of HS is correct, it is important to note that the outcome of continuous low-dose BPA exposure with respect to the risk for HS development might be influenced by individual variations of MMP11 expression in response to low-dose BPA.

Another interesting finding of our study is that ARNT2 mRNA levels are lower in the HS and CO groups compared with the control group. However, no significant differences were observed (P = 0.16 and 0.054, respectively). Compared with its homolog ARNT, ARNT2 has a more restricted pattern of expression, commonly found in the central nervous system and other developing organs, such as the kidney [26]. The main function of ARNT2 seems to be in organ development, since Arnt2 knockout mice and zebrafish suffer severe developmental defects and die shortly after birth [13]. Our study suggests limited evidence that inhibition of ARNT2 expression might be involved in the development of HS and CO. It is well known that ARNT2 acts as a common obligate partner for several members of the bHLH-PAS family, including aryl hydrocarbon receptor (AHR) and hypoxia-inducible factor (HIF)-1α [12]. Our previous study has reported that downregulation of ARNT2 expression can affect HIF signaling and metabolism in human breast cancer cells [27], [28]. HIF is well-known to play a key role in many developmental pathways. Further study to elucidate the role of dysregulated HIF signaling during genital tubercle development might increase our knowledge of the etiology of HS and CO.

We did not identify NTSR1 as a target of low-dose BPA in our previous genome-wide screen, probably owing to a lack of statistical significance. This may indicate that variability in NTSR1 gene expression among individuals might exist in response to low-dose BPA exposure [17]. This is in accord with our present findings that no significant effects to NTSR1 gene expression in response to low-dose BPA exposure were observed in all the three groups (Figure 2B). However, we found that NTSR1 expression in response to low-dose BPA was significantly different between the SNP rs5000770 AA group and the AG/GG group in child HS patients (P = 0.031). It has been reported that NTSR1 activation leads to cell proliferation, survival, mobility, and invasiveness in specific cancer cell types [29]. Furthermore, the transcription of neurotensin, mainly mediated by NTSR1, is enhanced by estradiol in human breast epithelial cells [20]. Of interest, NTSR1 expression in SNP rs5000770 AA carriers tends to be increased in response to low-dose BPA (1.16-fold compared with DMSO control) while in AG/GG carriers tends to be decreased (0.90-fold compared with DMSO control). One of the likely explanations for these findings is that SNP rs5000770 AA carriers might be more sensitive to the estrogen-like effect of low-dose BPA. However, we found no difference in ARNT2 expression or in ARNT2 splicing variants in mRNA obtained from hFFCs of child HS and CO patients of each SNP rs5000770 genotype. And also, it should be noted that no significant effects of low-dose BPA exposure were observed in NTSR1 gene expression compared with DMSO control in either AA or AG/GG groups. Further analyses will be needed to demonstrate the underlying mechanism by which this SNP might influence the inter-individual variations in sensitivity to the effect of low-dose BPA and increased risk of HS. It is known that ARNT2 is located on 15q24-25, while 15q24 microdeletion syndrome has been recently described as a recurrent, submicroscopic genomic imbalance found in individuals with developmental delay, craniofacial dysmorphism, digital and genital abnormalities (including HS) [30], [31], [32]. Other possible interpretations of our findings include the interactions between genetic loci located on 15q24-25, although further study is necessary to investigate this possibility.

In summary, we observed the specific effect of low-dose BPA inhibiting MMP11 expression in child HS but not control children and CO patients. Furthermore, we observed a significant difference in NTSR1 expression in response to low-dose BPA among HS patients with different SNP rs5000770 genotypes, suggesting that variability in genetic susceptibility to the effects of EEDs exposure might contribute to HS.

Supporting Information

Figure S1.

Expression of top genes with the highest standard deviations in response to low-dose BPA. Gene expression profiles of three hFFCs derived from HS patients were measured after exposure to 10 nM BPA for 24 h. Differentially expressed genes were listed according their standard deviations among the three cell lines. Data derived from our previous microarray study (Qin et al. PLoS One. 2012;7(5):e36711).

https://doi.org/10.1371/journal.pone.0052756.s001

(PPTX)

Figure S2.

Effect of BPA exposure on GAPDH expression. (A) MMP11 and (B) GAPDH expression following BPA treatment were measured in hFFCs derived from a control child without MGMs. Gene expression was normalized against GAPDH or beta-actin expression and set to 1 for the control DMSO-treated cells.

https://doi.org/10.1371/journal.pone.0052756.s002

(PPTX)

Table S1.

Summary of patient characteristics.

https://doi.org/10.1371/journal.pone.0052756.s003

(DOCX)

Acknowledgments

The authors gratefully acknowledge critical advice from Dr. Jun Kanno (National Institute of Health Sciences, Japan) and Dr. Yasunobu Aoki (National Institute for Environmental Studies, Japan), and technical support from Dr. Qin Zeng and Ms. Hiromi Akanuma (National Institute for Environmental Studies, Japan).

Author Contributions

Conceived and designed the experiments: XYQ HS TF J. Yoshinaga, J. Yonemoto, TO. Performed the experiments: XYQ HZ. Analyzed the data: XYQ AH. Contributed reagents/materials/analysis tools: YK K. Mizuno KU K. Muroya MM MF KK YH TO. Wrote the paper: XYQ HS.

References

  1. 1. Virtanen HE, Bjerknes R, Cortes D, Jorgensen N, Rajpert-De Meyts E, et al. (2007) Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 96: 611–616.
  2. 2. Toppari J, Virtanen HE, Main KM, Skakkebaek NE (2010) Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol 88: 910–919.
  3. 3. Vidaeff AC, Sever LE (2005) In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod Toxicol 20: 5–20.
  4. 4. Martin OV, Shialis T, Lester JN, Scrimshaw MD, Boobis AR, et al. (2008) Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis. Environ Health Perspect 116: 149–157.
  5. 5. Carbone P, Giordano F, Nori F, Mantovani A, Taruscio D, et al. (2007) The possible role of endocrine disrupting chemicals in the aetiology of cryptorchidism and hypospadias: a population-based case-control study in rural Sicily. Int J Androl 30: 3–13.
  6. 6. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM (2009) Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30: 75–95.
  7. 7. Watanabe M, Yoshida R, Ueoka K, Aoki K, Sasagawa I, et al. (2007) Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abnormalities. Hum Reprod 22: 1279–1284.
  8. 8. Qin XY, Kojima Y, Mizuno K, Ueoka K, Massart F, et al. (2012) Association of variants in genes involved in environmental chemical metabolism and risk of cryptorchidism and hypospadias. J Hum Genet 57: 434–441.
  9. 9. Hirose K, Morita M, Ema M, Mimura J, Hamada H, et al. (1996) cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol 16: 1706–1713.
  10. 10. Sekine H, Mimura J, Yamamoto M, Fujii-Kuriyama Y (2006) Unique and overlapping transcriptional roles of arylhydrocarbon receptor nuclear translocator (Arnt) and Arnt2 in xenobiotic and hypoxic responses. J Biol Chem 281: 37507–37516.
  11. 11. Hill AJ, Heiden TC, Heideman W, Peterson RE (2009) Potential roles of Arnt2 in zebrafish larval development. Zebrafish 6: 79–91.
  12. 12. Hankinson O (2008) Why does ARNT2 behave differently from ARNT? Toxicol Sci 103: 1–3.
  13. 13. Hsu HJ, Wang WD, Hu CH (2001) Ectopic expression of negative ARNT2 factor disrupts fish development. Biochem Biophys Res Commun 282: 487–492.
  14. 14. Barrow LL, Wines ME, Romitti PA, Holdener BC, Murray JC (2002) Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2): structure, gene mapping, polymorphisms, and candidate evaluation for human orofacial clefts. Teratology 66: 85–90.
  15. 15. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV (2007) Human exposure to bisphenol A (BPA). Reprod Toxicol 24: 139–177.
  16. 16. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, et al. (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113: 391–395.
  17. 17. Qin XY, Kojima Y, Mizuno K, Ueoka K, Muroya K, et al. (2012) Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One 7: e36711.
  18. 18. Qiao L, Tasian GE, Zhang H, Cao M, Ferretti M, et al. (2012) Androgen receptor is overexpressed in boys with severe hypospadias, and ZEB1 regulates androgen receptor expression in human foreskin cells. Pediatr Res 71: 393–398.
  19. 19. Vottero A, Minari R, Viani I, Tassi F, Bonatti F, et al. (2011) Evidence for epigenetic abnormalities of the androgen receptor gene in foreskin from children with hypospadias. J Clin Endocrinol Metab 96: E1953–1962.
  20. 20. Dupouy S, Viardot-Foucault V, Alifano M, Souaze F, Plu-Bureau G, et al. (2009) The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression. PLoS One 4: e4223.
  21. 21. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, et al. (2007) In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178–198.
  22. 22. Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, et al. (2009) MMP11: a novel target antigen for cancer immunotherapy. Clin Cancer Res 15: 4104–4113.
  23. 23. Vu TH, Werb Z (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14: 2123–2133.
  24. 24. Knorr E, Schmidtberg H, Vilcinskas A, Altincicek B (2009) MMPs regulate both development and immunity in the tribolium model insect. PLoS One 4: e4751.
  25. 25. Baskin LS, Erol A, Jegatheesan P, Li Y, Liu W, et al. (2001) Urethral seam formation and hypospadias. Cell Tissue Res 305: 379–387.
  26. 26. Maltepe E, Keith B, Arsham AM, Brorson JR, Simon MC (2000) The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia. Biochem Biophys Res Commun 273: 231–238.
  27. 27. Qin XY, Zaha H, Nagano R, Yoshinaga J, Yonemoto J, et al. (2011) Xenoestrogens down-regulate aryl-hydrocarbon receptor nuclear translocator 2 mRNA expression in human breast cancer cells via an estrogen receptor alpha-dependent mechanism. Toxicol Lett 206: 152–157.
  28. 28. Qin XY, Wei F, Yoshinaga J, Yonemoto J, Tanokura M, et al. (2011) siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells. FEBS Lett 585: 3310–3315.
  29. 29. Alifano M, Souaze F, Dupouy S, Camilleri-Broet S, Younes M, et al. (2010) Neurotensin receptor 1 determines the outcome of non-small cell lung cancer. Clin Cancer Res 16: 4401–4410.
  30. 30. Andrieux J, Dubourg C, Rio M, Attie-Bitach T, Delaby E, et al. (2009) Genotype-phenotype correlation in four 15q24 deleted patients identified by array-CGH. Am J Med Genet A 149A: 2813–2819.
  31. 31. McInnes LA, Nakamine A, Pilorge M, Brandt T, Jimenez Gonzalez P, et al. (2010) A large-scale survey of the novel 15q24 microdeletion syndrome in autism spectrum disorders identifies an atypical deletion that narrows the critical region. Mol Autism 1: 5.
  32. 32. Klopocki E, Graul-Neumann LM, Grieben U, Tonnies H, Ropers HH, et al. (2008) A further case of the recurrent 15q24 microdeletion syndrome, detected by array CGH. Eur J Pediatr 167: 903–908.